| dc.contributor | Departament de Salut |
| dc.date.accessioned | 2020-04-08T10:07:51Z |
| dc.date.available | 2020-04-08T10:07:51Z |
| dc.date.issued | 2020-04-03 |
| dc.identifier.citation | Coronavirus SARS-CoV-2: nota informativa sobre el tractament amb clozapina en el context de la crisi de la COVID-19 [fullet]. Barcelona: Departament de Salut; 2020. |
| dc.identifier.uri | https://hdl.handle.net/11351/4835 |
| dc.description | Atypical antipsychotics; Coronavirus SARS-CoV-2; COVID-19; 2019-nCoV |
| dc.language.iso | cat |
| dc.publisher | Departament de Salut |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Esquizofrènia - Tractament |
| dc.subject | Antipsicòtics |
| dc.subject | COVID-19 (Malaltia) - Prevenció |
| dc.subject.mesh | Schizophrenia |
| dc.subject.mesh | /prevention & control |
| dc.subject.mesh | /drug therapy |
| dc.subject.mesh | Clozapine |
| dc.subject.mesh | Coronavirus Infections |
| dc.title | Coronavirus SARS-CoV-2: nota informativa sobre el tractament amb clozapina en el context de la crisi de la COVID-19 [fullet] |
| dc.type | info:eu-repo/semantics/other |
| dc.subject.decs | esquizofrenia |
| dc.subject.decs | /prevención & control |
| dc.subject.decs | /tratamiento farmacológico |
| dc.subject.decs | clozapina |
| dc.subject.decs | infecciones por Coronavirus |
| dc.type.subtype | Fullet |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |